Carbapenem-hydrolysing beta-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal.
Cardoso
O
O
Sousa
J C
JC
Leitão
R
R
Peixe
L
L
D001426:Bacterial Proteins; D015780:Carbapenems / Q000378:metabolism* / Q000494:pharmacology*; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D011174:Portugal; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology*; D012141:Respiratory Tract Infections / Q000382:microbiology; D013845:Thienamycins / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000382:microbiology; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000378:metabolism*
D001426:Bacterial Proteins; D015780:Carbapenems; D013845:Thienamycins; D015378:Imipenem; D001618:beta-Lactamases; C063912:carbapenemase